Affiliate disclosure: this article contains affiliate links. As an Amazon Associate, UsefulVitamins.com earns from qualifying purchases at no extra cost to you.
Fatty15 markets its C15:0 capsule as the successor to fish oil, and the top search results for this comparison are mostly written by the company itself. This page is the independent version. We read the actual studies behind both fatty acids, checked who paid for them, and did the price math. The two supplements are answering very different evidence questions, and that difference should drive your decision. The fish oil picks further down are the same ones we would hand to our own family, which is the standard every recommendation on this site has to clear.
Before you decide
A quick filter before the head-to-head, because neither product is right for everyone.
Skip both if your diet already covers the bases. If you eat fatty fish about twice a week and include some whole-fat dairy, you are already getting meaningful EPA, DHA, and trace C15:0 from food, which is the pattern most of the supportive observational research is actually built on. Our complete guide to omega-3 covers food sources in detail.
Talk to your doctor first if you take anticoagulant or antiplatelet medication, since high-dose omega-3 can affect bleeding, or if you are pregnant, nursing, or managing a diagnosed heart or liver condition. Nothing here is medical advice; it is an evidence audit to help you ask better questions.
This comparison is for the person who has seen fatty15's "better than omega-3" advertising and wants to know whether to switch, to stack both, or to save the money. That is the question we answer below.
What you're actually buying
The two products have almost nothing in common chemically, which is the first thing the marketing glosses over.
Fatty15 is a one-a-day capsule containing 100 mg of C15:0, also called pentadecanoic acid, in a patented vegan form the company calls FA15. C15:0 is an odd-chain saturated fat found naturally in trace amounts in whole dairy fat and some fish. Interest in it took off after a 2020 paper in Scientific Reports linked higher circulating C15:0 levels to lower cardiometabolic risk and showed benefits in cell and animal models. The company argues it may be the first "essential" fatty acid discovered in decades. That claim is still a hypothesis, not an accepted classification.
Fish oil delivers the long-chain omega-3s EPA and DHA, polyunsaturated fats your body uses in cell membranes, eicosanoid signaling, and triglyceride metabolism. Typical products supply 500 to 1,300 mg of combined EPA and DHA per serving, and the NIH Office of Dietary Supplements maintains a thorough evidence summary on them. Form matters for absorption, which is why we compare triglyceride, ethyl ester, and krill forms separately in our omega-3 bioavailability breakdown.
So one capsule gives you 100 mg of a saturated fat with early-stage evidence. The other gives you roughly five to thirteen times more active fatty acid, from a family with a fifty-year research record. Neither can do the other's job.
Head-to-head: who funded the evidence
This is the decisive dimension, because fatty15's advertising leans on the phrase "3x the cellular benefits of omega-3." We traced that claim to its source.
It comes from a 2022 cell-based study in PLoS ONE that compared purified C15:0 against EPA across twelve human cell systems in a dish. C15:0 showed activity on more biomarkers than EPA did. The funding statement is worth quoting: the work was financed through an Office of Naval Research award to Epitracker, Inc., and the lead author "receives salary from Epitracker, Inc. and Seraphina Therapeutics, Inc." Seraphina is the company that sells fatty15, and it holds the licensed patents. The flagship better-than-omega-3 study was run and funded by the people selling the product, and it was run in cell cultures, not people.
The foundational 2020 Scientific Reports paper carries the same structure. Its competing-interests statement says Epitracker financed the studies, and the lead author co-founded both Epitracker and Seraphina. None of this makes the science fraudulent. Industry-funded research is normal and often sound. But independent replication is the step that turns promising into proven, and C15:0 has very little of it so far.
The closest thing to an independent test is a 12-week randomized trial in The Journal of Nutrition from 2024, run on an NIH grant but also supported by Seraphina, which supplied the capsules and matching placebo. Thirty young adults with overweight or obesity took 200 mg of C15:0 or placebo daily. Blood C15:0 levels rose modestly, the supplement was safe, and across the full cohort exactly one biomarker, the liver enzyme GGT, improved significantly versus placebo. That is a real but thin human result: interesting liver signals, no demonstrated effect on weight, lipids, or inflammation at the group level, in a trial of thirty people.
Now the fish oil side. REDUCE-IT, published in the New England Journal of Medicine, randomized 8,179 high-risk patients to 4 g per day of purified EPA (icosapent ethyl) or placebo and found a 25% relative reduction in major cardiovascular events. The picture is genuinely mixed, though, and we will not pretend otherwise. The STRENGTH trial in JAMA tested a different high-dose EPA+DHA formulation in 13,078 patients and found no benefit. A Cochrane review of 79 randomized trials concluded that ordinary EPA/DHA supplementation has little or no effect on mortality or cardiovascular events, while confirming one solid, dose-dependent effect: triglycerides drop by roughly 15%.
Here is the honest framing. Omega-3's weaknesses are known because tens of thousands of people have been through outcome trials. C15:0 has not yet earned the trials that would reveal its weaknesses. A fatty acid that has survived that much scrutiny, with at least one strong positive outcome trial and an undisputed triglyceride effect, sits in a different evidence class than one small 30-person study plus company-funded cell work.
The numbers side by side
| Dimension | fatty15 (C15:0) | Fish oil (EPA+DHA) |
|---|---|---|
| Active ingredient | 100 mg pentadecanoic acid (FA15), vegan | Typically 500-1,300 mg combined EPA+DHA per serving |
| Fatty acid class | Odd-chain saturated fat | Long-chain polyunsaturated omega-3 |
| Largest human RCT | 30 participants, 12 weeks (2024) | 13,078 participants (STRENGTH); 8,179 (REDUCE-IT) |
| Hard-outcome trial results | None published | Mixed: REDUCE-IT positive, STRENGTH null |
| Best-established human effect | Raised plasma C15:0; GGT decrease in one small RCT | About 15% triglyceride reduction (Cochrane, 79 RCTs) |
| Key studies funded by | Epitracker/Seraphina (seller) plus Navy grants; one NIH-funded RCT | Mix of industry and large independent/public funders |
| Cost per day | About $1.33 subscribed, $1.67 one-time, as of August 2026 | Varies widely by brand and form; see our tested picks |
| Where sold | Direct (fatty15.com), official Amazon storefront, practitioner platforms | Every major retailer; many third-party-tested options |
| Food sources | Trace amounts in whole dairy fat, some fish | Fatty fish (salmon, sardines, mackerel) |
Two cells deserve emphasis. "None published" in the hard-outcomes row is the whole comparison in miniature, and the cost row shows you are paying a premium for the newer, less-tested molecule.
Price per day: the honest math
Fatty15 sells a 90-day starter kit for about $150 one-time or $119.95 on subscription as of August 2026, which the company states works out to $39.98 a month. Per day, that is about $1.33 subscribed or roughly $1.67 without the subscription, for 100 mg of C15:0.
Put differently, you are paying around $13 to $17 per gram of active fatty acid. Quality fish oil delivers EPA and DHA at a small fraction of that per-gram cost, though exact prices swing enough by brand, form, and retailer that we keep current numbers on the product cards in our best omega-3 supplements roundup rather than quoting a single figure here.
There is also a free option on the C15:0 side. The trace amounts linked to benefit in observational studies came from food, mostly whole-fat dairy. A daily serving of whole milk or butter costs pennies. Whether concentrated supplemental C15:0 beats dietary C15:0 is exactly the kind of question the missing large trials would answer.
For fish oil, dose is what drives cost, and most people need less than they think. Work out your personal EPA+DHA target with our omega-3 dosage guide before you pay for a high-potency product you may not need.
Who should pick fatty15 (and who fish oil)
Fatty15 is the more defensible buy for a narrow group. If you are strictly plant-based, avoid all dairy, and want C15:0 exposure without changing your diet, fatty15 is essentially the only concentrated option, and its vegan sourcing is a genuine point of difference from marine oils. The same goes for the early-adopter who has read the studies, understands the funding caveats, and wants in before the big trials exist. The 2024 trial found no safety concerns at 200 mg daily, twice the label dose, which is reassuring as far as twelve weeks in thirty people can reassure.
Fish oil is the pick for almost everyone else. If your goal is high triglycerides, general cardiovascular support, or simply covering a low-fish diet, EPA and DHA have the human data, the established dosing, and the third-party testing infrastructure. You can verify what is in the bottle through USP or IFOS certification, choose your absorption form deliberately, and pay less doing it. Use our EPA/DHA calculator to translate any label into an actual daily dose.
And the replace-or-stack question that brought most readers here: do not replace fish oil with fatty15 expecting the same effects, because a saturated odd-chain fat cannot substitute for polyunsaturated omega-3s in membranes or triglyceride metabolism. Stacking both is biologically coherent and appears safe on current evidence, but only the fish oil half of the stack has outcome data. If the budget covers one bottle, the evidence says make it the omega-3.
What to look for when buying
If you buy fatty15, buy directly. The company sells through fatty15.com, its official Amazon storefront, and practitioner platforms such as Fullscript, so listings anywhere else deserve suspicion. The subscription price is about 20% below one-time pricing, but note that the trial kit auto-enrolls you into 90-day refills at $119.95, so calendar the cancellation window if you only want to test it.
For fish oil, four checks separate good bottles from mediocre ones. Read the EPA+DHA line, not the "fish oil 1000 mg" line, because concentration varies threefold between products. Prefer third-party certification (USP, NSF, or IFOS) for purity and label accuracy. Check the form, since triglyceride-form oils absorb better than ethyl esters at the same labeled dose. And check freshness practices, because oxidized fish oil is both unpleasant and counterproductive. The picks below passed all four checks.
As an Amazon Associate, UsefulVitamins.com earns from qualifying purchases at no extra cost to you. We only recommend products supported by published research or third-party testing.
FAQ
Is fatty15 really 3x better than omega-3?
That number comes from a 2022 cell-culture study funded by the companies behind fatty15, which counted how many biomarkers each fatty acid moved across twelve cell systems. Cells in a dish are a starting point for research, not proof of benefit in people. No human trial has compared C15:0 against fish oil on any health outcome.
Can I take fatty15 and fish oil together?
Biologically they do different jobs, so stacking is coherent and no interaction has been reported. The 2024 randomized trial found 200 mg of C15:0 daily safe over 12 weeks. If you take blood thinners or prescription lipid medication, clear the combination with your doctor first, mainly because of the omega-3 half.
Does C15:0 have any human evidence at all?
Yes, two kinds. Observational studies link higher blood C15:0 to lower cardiometabolic risk, though those levels mostly reflect dairy intake and cannot prove cause. And one 30-person randomized trial (NIH grant, with support from Seraphina) found that supplementation raised blood levels and improved one liver enzyme, with no significant group-level change in weight, lipids, or inflammation over 12 weeks.
Is C15:0 an essential fatty acid like omega-3?
Not officially. The researchers behind fatty15 have proposed it may be conditionally essential, but no nutrition authority currently classifies it that way. Omega-3s (as ALA) hold that formal status, and EPA/DHA have recognized intake recommendations from bodies summarized by the NIH Office of Dietary Supplements.
Can I just get C15:0 from food?
The observational research linking C15:0 to better health measured levels typical of people who consume whole-fat dairy products, and small amounts also occur in some fish. A daily serving of whole milk, full-fat yogurt, or butter provides trace C15:0 at grocery-store prices. Whether 100 mg in a capsule outperforms that dietary pattern has not been tested head to head.
Why is fish oil so much cheaper?
Scale and competition. Hundreds of manufacturers compete on a commodity ingredient with mature supply chains, while C15:0 in the FA15 form is patented and sold by a single company. Patents reward discovery, but they also mean you pay a monopoly price during the years before the evidence matures.
The bottom line
Fatty15 is an interesting molecule wearing a marketing suit two sizes too big. The observational signal around C15:0 is real, the safety record so far is clean, and we genuinely hope the large independent trials get run. But as of August 2026, its headline claims rest on cell studies funded by its own maker, and its only randomized human trial moved one liver enzyme in thirty people. Fish oil's record is imperfect and openly contested, which is what a mature evidence base looks like. Between a fatty acid with mixed results from trials of 20,000+ people and one that has not yet been asked the hard questions, the evidence advantage stays with fish oil. Buy fatty15 as a well-funded experiment on yourself if that appeals to you. Buy omega-3 for the reasons the trials support, at the dose your situation actually calls for.
